1 kit of 10 GLP3 20mg vials
If not locally in stack may need to allow 2 -3 weeks for delivery
GLP3 peptide is a synthetic, investigational triple receptor agonist for the research on treatment of obesity, type 2 diabetes, and related metabolic conditions. It targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors, aiming to enhance weight loss, improve glycemic control, and support metabolic health.
-
Mechanism of Action: GLP3 is a 39-amino-acid peptide engineered from a GIP backbone, featuring non-coded amino acids (Aib2, Aib20, aMeL13) and a C20 fatty diacid conjugation for stability and extended half-life (~6 days). This allows for once-weekly subcutaneous administration.
-
Clinical Efficacy: In Phase 2 and Phase 3 trials (e.g., TRIUMPH-4), GLP3 demonstrated up to 24.4% body weight reduction at 48 weeks and 71.2 lbs (32.3 kg) average weight loss at 68 weeks.
-
 Research also showed it may significantly reduce HbA1c, liver fat, and pain in osteoarthritis patients.
GLP3 20mg! is designed to help your research subjects shed pounds and achieve weight loss objectives for your research studies.
GLP3 works by targeting specific pathways that regulate appetite and metabolism. By enhancing the test subjects natural ability to burn stored fat, this powerful formula may be exactly what you have been waiting for and certainly worth running for your studies.
This new substance is backed by extensive research and new clinical trials that are ongoing with new ones starting all the time..
Reviews
There are no reviews yet.